Advertisement
Review| Volume 159, ISSUE 2, P267-272, December 2011

Download started.

Ok

Contribution of myo-inositol and melatonin to human reproduction

      Abstract

      Diet is a critical factor for the development of both embryo and fetus, as well as maternal health. In particular, two natural molecules have been shown to exert beneficial effects on fertility, pregnancy wellness and embryo development: myo-inositol and melatonin, whose requirements increase during pregnancy.
      In the present review, we summarize the most important functions of melatonin and myo-inositol on male and female reproductive systems (oocyte quality and development, sperm quality), on the maintenance of a physiological pregnancy and on embryo development.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Andersen H.S.
        • Gambling L.
        • Holtrop G.
        • McArdle H.J.
        Maternal iron deficiency identifies critical windows for growth and cardiovascular development in the rat postimplantation embryo.
        J Nutr. 2006; 136: 1171-1177
        • Steegers E.
        Begin at the beginning: some reflections on future peri-conceptional and obstetric care and research in the Netherlands.
        Eur Clin Obstet Gynaecol. 2005; 1: 2
        • Allen L.H.
        Multiple micronutrients in pregnancy and lactation: an overview.
        Am J Clin Nutr. 2005; 81: 1206S-1212S
        • Cavalli P.
        • Tedoldi S.
        • Riboli B.
        Inositol supplementation in pregnancies at risk of apparently folate-resistant NTDs.
        Birth Defects Res A Clin Mol Teratol. 2008; 82: 540-542
        • Tamura H.
        • Nakamura Y.
        • Terron M.P.
        • et al.
        Melatonin and pregnancy in the human.
        Reprod Toxicol. 2008; 25: 291-303
        • Diaz J.R.
        • de las Cagigas A.
        • Rodriguez R.
        Micronutrient deficiencies in developing and affluent countries.
        Eur J Clin Nutr. 2003; 57: S70-S72
      1. Best MD, Zhang H, Prestwich GD. Inositol polyphosphates, diphosphoinositol polyphosphates and phosphatidylinositol polyphosphate lipids: structure, synthesis, and development of probes for studying biological activity. Nat Prod Rep 2010;27(October (10)):1403–30.

        • Kutateladze T.G.
        Translation of the phosphoinositide code by PI effectors.
        Nat Chem Biol. 2011; 6: 507-513
        • Stachecki J.J.
        • Armant D.R.
        Transient release of calcium from inositol 1,4,5-trisphosphate-specific stores regulates mouse preimplantation development.
        Development. 1996; 122: 2485-2496
        • Silman R.E.
        • Leone R.M.
        • Hooper R.J.
        • Preece M.A.
        Melatonin, the pineal gland and human puberty.
        Nature. 1979; 282: 301-303
        • Arendt J.
        Melatonin and the mammalian pineal gland.
        1st ed. London Chapman & Hall, 1995 (p. 17)
        • Tan D.X.
        • Manchester L.C.
        • Terron M.P.
        • Flores L.J.
        • Reiter R.J.
        One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?.
        J Pineal Res. 2007; 42: 28-42
        • Tamura H.
        • Nakamura Y.
        • Korkmaz A.
        • et al.
        Melatonin and the ovary: physiological and pathophysiological implications.
        Fertil Steril. 2009; 92: 328-343
        • Sewerynek E.
        • Reiter R.J.
        • Melchiorri D.
        • Ortiz G.G.
        • Lewinski A.
        Oxidative damage in the liver induced by ischemia-reperfusion: protection by melatonin.
        Hepatogastroenterology. 1996; 43: 898-905
        • Melchiorri D.
        • Reiter R.J.
        • Chen L.D.
        • Sewerynek E.
        • Nistico G.
        Melatonin affords protection against kainate-induced in vitro lipid peroxidation in brain.
        Eur J Pharmacol. 1996; 305: 239-242
        • Pieri C.
        • Marra M.
        • Gaspar R.
        • Damjanovich S.
        Melatonin protects LDL from oxidation but does not prevent the apolipoprotein derivatization.
        Biochem Biophys Res Commun. 1996; 222: 256-260
        • Cuzzocrea S.
        • Costantino G.
        • Caputi A.P.
        Protective effect of melatonin on cellular energy depletion mediated by peroxynitrite and poly (ADP-ribose) synthetase activation in a non-septic shock model induced by zymosan in the rat.
        J Pineal Res. 1998; 25: 78-85
        • Princ F.G.
        • Maxit A.G.
        • Cardalda C.
        • Batlle A.
        • Juknat A.A.
        In vivo protection by melatonin against delta-aminolevulinic acid-induced oxidative damage and its antioxidant effect on the activity of haem enzymes.
        J Pineal Res. 1998; 24: 1-8
        • Garcia J.J.
        • Reiter R.J.
        • Guerrero J.M.
        • et al.
        Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation.
        FEBS Lett. 1997; 408: 297-300
      2. Reiter RJ, Tan DX, Fuentes-Broto L. Melatonin: a multitasking molecule. Prog Brain Res 2010;181:127–51.

      3. du Plessis SS, Hagenaar K, Lampiao F. The in vitro effects of melatonin on human sperm function and its scavenging activities on NO and ROS. Andrologia 2010;42(April (2)):112–6.

        • Bornman M.S.
        • Oosthuizen J.M.
        • Barnard H.C.
        • Schulenburg G.W.
        • Boomker D.
        • Reif S.
        Melatonin and sperm motility.
        Andrologia. 1989; 21: 483-485
        • van Vuuren R.J.
        • Pitout M.J.
        • van Aswegen C.H.
        • Theron J.J.
        Putative melatonin receptor in human spermatozoa.
        Clin Biochem. 1992; 25: 125-127
        • Itoh M.T.
        • Ishizuka B.
        • Kuribayashi Y.
        • Amemiya A.
        • Sumi Y.
        Melatonin, its precursors, and synthesizing enzyme activities in the human ovary.
        Mol Hum Reprod. 1999; 5: 402-408
        • Espey L.L.
        Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction.
        Biol Reprod. 1994; 50: 233-238
        • Tamura H.
        • Takasaki A.
        • Miwa I.
        • et al.
        Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate.
        J Pineal Res. 2008; 44: 280-287
        • Beemster P.
        • Groenen P.
        • Steegers-Theunissen R.
        Involvement of inositol in reproduction.
        Nutr Rev. 2002; 60: 80-87
        • Goud P.T.
        • Goud A.P.
        • Leybaert L.
        • et al.
        Inositol 1,4,5-trisphosphate receptor function in human oocytes: calcium responses and oocyte activation-related phenomena induced by photolytic release of InsP(3) are blocked by a specific antibody to the type I receptor.
        Mol Hum Reprod. 2002; 8: 912-918
        • Lowther K.M.
        • Weitzman V.N.
        • Maier D.
        • Mehlmann L.M.
        Maturation, fertilization, and the structure and function of the endoplasmic reticulum in cryopreserved mouse oocytes.
        Biol Reprod. 2009; 81: 147-154
        • Goud P.T.
        • Goud A.P.
        • Van Oostveldt P.
        • Dhont M.
        Presence and dynamic redistribution of type I inositol 1,4,5-trisphosphate receptors in human oocytes and embryos during in-vitro maturation, fertilization and early cleavage divisions.
        Mol Hum Reprod. 1999; 5: 441-451
        • Chiu T.T.
        • Rogers M.S.
        • Briton-Jones C.
        • Haines C.
        Effects of myo-inositol on the in-vitro maturation and subsequent development of mouse oocytes.
        Hum Reprod. 2003; 18: 408-416
        • Baillargeon J.P.
        • Nestler J.E.
        Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?.
        J Clin Endocrinol Metab. 2006; 91: 22-24
        • Gerli S.
        • Mignosa M.
        • Di Renzo G.C.
        Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial.
        Eur Rev Med Pharmacol Sci. 2003; 7: 151-159
        • Gerli S.
        • Papaleo E.
        • Ferrari A.
        • Di Renzo G.C.
        Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS.
        Eur Rev Med Pharmacol Sci. 2007; 11: 347-354
        • Papaleo E.
        • Unfer V.
        • Baillargeon J.P.
        • et al.
        Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction.
        Gynecol Endocrinol. 2007; 23: 700-703
        • Genazzani A.D.
        • Lanzoni C.
        • Ricchieri F.
        • Jasonni V.M.
        Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome.
        Gynecol Endocrinol. 2008; 24: 139-144
        • Baillargeon J.P.
        • Diamanti-Kandarakis E.
        • Ostlund Jr., R.E.
        • Apridonidze T.
        • Iuorno M.J.
        • Nestler J.E.
        Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome.
        Diabetes Care. 2006; 29: 300-305
        • Giordano D.
        • Corrado F.
        • Santamaria A.
        • et al.
        Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study.
        Menopause. 2011; 18: 102-104
        • Chauvin T.R.
        • Griswold M.D.
        Characterization of the expression and regulation of genes necessary for myo-inositol biosynthesis and transport in the seminiferous epithelium.
        Biol Reprod. 2004; 70: 744-751
        • Hinton B.T.
        • White R.W.
        • Setchell B.P.
        Concentrations of myo-inositol in the luminal fluid of the mammalian testis and epididymis.
        J Reprod Fertil. 1980; 58: 395-399
        • Colone M.
        • Marelli G.
        • Unfer V.
        • Bozzuto G.
        • Molinari A.
        • Stringaro A.
        Inositol activity in oligoasthenoteratospermia – an in vitro study.
        Eur Rev Med Pharmacol Sci. 2010; 14: 891-896
        • Liu D.Y.
        • Clarke G.N.
        • Baker H.W.
        Hyper-osmotic condition enhances protein tyrosine phosphorylation and zona pellucida binding capacity of human sperm.
        Hum Reprod. 2006; 21: 745-752
        • Cryns K.
        • Shamir A.
        • Van Acker N.
        • et al.
        IMPA1 is essential for embryonic development and lithium-like pilocarpine sensitivity.
        Neuropsychopharmacology. 2008; 33: 674-684
        • Martinez-Heredia J.
        • de Mateo S.
        • Vidal-Taboada J.M.
        • Ballesca J.L.
        • Oliva R.
        Identification of proteomic differences in asthenozoospermic sperm samples.
        Hum Reprod. 2008; 23: 783-791
        • Walsh S.W.
        • Wang Y.
        Secretion of lipid peroxides by the human placenta.
        Am J Obstet Gynecol. 1993; 169: 1462-1466
        • Mover-Lev H.
        • Ar A.
        Changes in enzymatic antioxidant activity in pregnant rats exposed to hyperoxia or hypoxia.
        Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1997; 118: 353-359
        • Brown M.A.
        • Lindheimer M.D.
        • de Swiet M.
        • Van Assche A.
        • Moutquin J.M.
        The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP).
        Hypertens Pregnancy. 2001; 20: IX-XIV
        • Morris J.M.
        • Gopaul N.K.
        • Endresen M.J.
        • et al.
        Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia.
        Br J Obstet Gynaecol. 1998; 105: 1195-1199
        • Wang Y.
        • Walsh S.W.
        Placental mitochondria as a source of oxidative stress in pre-eclampsia.
        Placenta. 1998; 19: 581-586
        • Vanderlelie J.
        • Venardos K.
        • Clifton V.L.
        • Gude N.M.
        • Clarke F.M.
        • Perkins A.V.
        Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae.
        Placenta. 2005; 26: 53-58
        • Milczarek R.
        • Klimek J.
        • Zelewski L.
        Melatonin inhibits NADPH-dependent lipid peroxidation in human placental mitochondria.
        Horm Metab Res. 2000; 32: 84-85
        • Simko F.
        • Paulis L.
        Melatonin as a potential antihypertensive treatment.
        J Pineal Res. 2007; 42: 319-322
        • Pagni C.A.
        • Zenga F.
        Posttraumatic epilepsy with special emphasis on prophylaxis and prevention.
        Acta Neurochir Suppl. 2005; 93: 27-34
        • Kurcer Z.
        • Oguz E.
        • Ozbilge H.
        • et al.
        Melatonin protects from ischemia/reperfusion-induced renal injury in rats: this effect is not mediated by proinflammatory cytokines.
        J Pineal Res. 2007; 43: 172-178
        • Schenker S.
        • Yang Y.
        • Perez A.
        • et al.
        Antioxidant transport by the human placenta.
        Clin Nutr. 1998; 17: 159-167
        • Thomas L.
        • Purvis C.C.
        • Drew J.E.
        • Abramovich D.R.
        • Williams L.M.
        Melatonin receptors in human fetal brain: 2-[(125)I]iodomelatonin binding and MT1 gene expression.
        J Pineal Res. 2002; 33: 218-224
        • Okatani Y.
        • Watanabe K.
        • Hayashi K.
        • Wakatsuki A.
        • Sagara Y.
        Melatonin inhibits vasospastic action of hydrogen peroxide in human umbilical artery.
        J Pineal Res. 1997; 22: 163-168
        • Gupta S.
        • Agarwal A.
        • Banerjee J.
        • Alvarez J.G.
        The role of oxidative stress in spontaneous abortion and recurrent pregnancy loss: a systematic review.
        Obstet Gynecol Surv. 2007; 62 (quiz 53–4): 335-347
        • Sane A.S.
        • Chokshi S.A.
        • Mishra V.V.
        • Barad D.P.
        • Shah V.C.
        • Nagpal S.
        Serum lipoperoxides in induced and spontaneous abortions.
        Gynecol Obstet Invest. 1991; 31: 172-175
        • Nakamura Y.
        • Tamura H.
        • Kashida S.
        • et al.
        Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy.
        J Pineal Res. 2001; 30: 29-33
        • Jahnke G.
        • Marr M.
        • Myers C.
        • Wilson R.
        • Travlos G.
        • Price C.
        Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats.
        Toxicol Sci. 1999; 50: 271-279
        • Vazquez M.I.
        • Forcada F.
        • Casao A.
        • Sosa C.
        • Palacin I.
        • Abecia J.A.
        Effects of melatonin and undernutrition on the viability of ovine embryos during anestrus and the breeding season.
        Anim Reprod Sci. 2009; 112: 83-94
        • Sharkey J.T.
        • Puttaramu R.
        • Word R.A.
        • Olcese J.
        Melatonin synergizes with oxytocin to enhance contractility of human myometrial smooth muscle cells.
        J Clin Endocrinol Metab. 2009; 94: 421-427
      4. Sharkey JT, Cable C, Olcese J. Melatonin sensitizes human myometrial cells to oxytocin in a protein kinase C alpha/extracellular-signal regulated kinase-dependent manner. J Clin Endocrinol Metab 2010;95(June (6)):2902–8.

        • Wald N.J.
        Folic acid and the prevention of neural tube defects: the need for public health action.
        Bibl Nutr Dieta. 1995; : 56-65
        • Carter M.
        • Ulrich S.
        • Oofuji Y.
        • Williams D.A.
        • Ross M.E.
        Crooked tail (Cd) models human folate-responsive neural tube defects.
        Hum Mol Genet. 1999; 8: 2199-2204
        • Seller M.J.
        Vitamins, folic acid and the cause and prevention of neural tube defects.
        Ciba Found Symp. 1994; 181 (discussion 73–9): 161-173
      5. Corrado F, D’Anna R, Di Vieste G, et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabet Med 2011;March 12.

        • Scioscia M.
        • Gumaa K.
        • Rademacher T.W.
        The link between insulin resistance and preeclampsia: new perspectives.
        J Reprod Immunol. 2009; 82: 100-105
        • Thadhani R.
        • Ecker J.L.
        • Kettyle E.
        • Sandler L.
        • Frigoletto F.D.
        Pulse pressure and risk of preeclampsia: a prospective study.
        Obstet Gynecol. 2001; 97: 515-520
        • Sibai B.M.
        • Ewell M.
        • Levine R.J.
        • et al.
        Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group.
        Am J Obstet Gynecol. 1997; 177: 1003-1010
        • Thadhani R.
        • Stampfer M.J.
        • Hunter D.J.
        • Manson J.E.
        • Solomon C.G.
        • Curhan G.C.
        High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy.
        Obstet Gynecol. 1999; 94: 543-550
        • Timar O.
        • Sestier F.
        • Levy E.
        Metabolic syndrome X: a review.
        Can J Cardiol. 2000; 16: 779-789
        • Wolf M.
        • Kettyle E.
        • Sandler L.
        • Ecker J.L.
        • Roberts J.
        • Thadhani R.
        Obesity and preeclampsia: the potential role of inflammation.
        Obstet Gynecol. 2001; 98: 757-762
        • Estelles A.
        • Gilabert J.
        • Aznar J.
        • Loskutoff D.J.
        • Schleef R.R.
        Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia.
        Blood. 1989; 74: 1332-1338
        • Scioscia M.
        • Paine M.A.
        • Gumaa K.
        • Rodeck C.H.
        • Rademacher T.W.
        Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension.
        J Matern Fetal Neonatal Med. 2008; 21: 581-585
        • Roberts D.
        • Dalziel S.
        Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.
        Cochrane Database Syst Rev. 2006; 3: CD004454
        • Hallman M.
        • Feldman B.H.
        • Kirkpatrick E.
        • Gluck L.
        Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn. Study of the minor surfactant phospholipids in newborns.
        Pediatr Res. 1977; 11: 714-720
        • Di Renzo G.C.
        • Anceschi M.M.
        • Cosmi E.V.
        Lung surfactant enhancement in utero.
        Eur J Obstet Gynecol Reprod Biol. 1989; 32: 1-11
      6. UNCE. http://www.unece.org/stats/trends2005/family.htm; 2005.